Salidroside is one of the major phenolic glycosides in Rhodiola, which has been reported to possess various biological activities. In the present study the in vivo deglycosylation metabolism of salidroside was investigated and its aglycone p-tyrosol but not the original salidroside was identified as the main form in rat tissues following the administration of salidroside. After the i.v. administration of salidroside at a dose of 50 mg/kg in rats, salidroside was quantified only in the liver, kidney and heart tissues. The highest level of p-tyrosol was detected in the heart, followed by the spleen, kidney, liver and lungs, in order. Salidroside was detected only in the liver, in contrast, p-tyrosol was detectable in most tissues except the brain, and the kidney tissues contained a significant amount of p-tyrosol compared to the other tissues after the i.g. administration of 100 mg/kg salidroside. The excretion behaviour revealed that the administrated salidroside mainly eliminated in the form of salidroside but not its aglycone metabolite p-tyrosol through urine. After i.v. and i.g. administration in rats, 64.00% and 23.80% of the total dose was excreted through urine in the form of salidroside, respectively. In addition, 0.19% and 2.25% of the dose was excreted in the form of p-tyrosol through urine after i.v. and i.g. administration, respectively. The faecal salidroside and p-tyrosol concentrations were 0.3% and 1.48% of the total dose after i.v. administration, respectively. After the i.g. administration of salidroside, trace salidroside and p-tyrosol were quantified in faeces within 72 h. In addition, the biliary excretion levels of salidroside after i.v. and i.g. administration were 2.86% and 0.02% of the dose, respectively. The obtained results show that salidroside was extensively metabolised to its aglycone p-tyrosol and distributed to various organs and the orginal salidroside was cleared rapidly through urine following the administration of salidroside.

Accurate determination of polycyclic aromatic hydrocarbons (PAHs) in surface waters is necessary for protection of the environment from adverse effects that can occur at concentrations which require preconcentration to be detected. In this study, an effective solid phase extraction (SPE) method based on cetyltrimethylammonium bromide (CTAB)-coated Fe3O4 magnetic nanoparticles (MNPs) was developed for extraction of trace quantities of PAHs from natural waters. An enrichment factor of 800 was achieved within 5 min by use of 100 mg of Fe3O4 MNPs and 50 mg of CTAB. Compared with conventional liquid-liquid extraction (LLE), C18 SPE cartridge and some newly developed methods, the SPE to determine bioaccessible fraction was more convenient, efficient, time-saving, and cost-effective. To evaluate the performance of this novel sorbent, five natural samples including rainwater, river waters, wastewater, and tap water spiked with 15 PAHs were analyzed by use of ultraperformance, liquid chromatography (UPLC) with fluorescence detection (FLD). Limits of determination (LOD) of PAHs (log Kow ≥ 4.46) ranged from 0.4 to 10.3 ng/L, with mean recoveries of 87.95 ± 16.16, 85.92 ± 10.19, 82.89 ± 5.25, 78.90 ± 9.90, and 59.23 ± 3.10% for rainwater, upstream and downstream river water, wastewater, and tap water, respectively. However, the effect of dissolved organic matter (DOM) on recovery of PAHs varied among matrixes. Because of electrostatic adsorption and hydrophobicity, DOM promoted adsorption of Fe3O4 MNPs to PAHs from samples of water from the field. This result was different than the effect of DOM under laboratory conditions. Because of competitive adsorption with the site of action on the surface of Fe3O4 MNPs for CTAB, recoveries of PAHs were inversely proportional to concentrations of Ca(2+) and Mg(2+). This novel sorbent based on nanomaterials was effective at removing PAHs at environmentally relevant concentrations from waters containing relevant concentrations of both naturally occurring organic matter and hardness metals.

In the present work, the salidroside metabolite profile in rat urine was investigated, and subsequently the metabolic pathways of salidroside were proposed. After administrations of salidroside at an oral dose of 100 or 500 mg/kg, rat urine samples were collected and pretreated with methanol to precipitate the proteins. The pretreated samples were analyzed by an Acquity ultraperformance liquid chromatography (UPLC) coupled with an HSS T3 column and detected by quadrupole time-of-flight mass spectrometry (Q-TOF-MS) or high-performance liquid chromatography coupled with hybrid triple-quadrupole linear ion trap mass spectrometry (HPLC/Q-trap-MS). A total of eight metabolites were detected and identified on the basis of the characteristics of their protonated ions in the urine samples. The results elucidated that salidroside was metabolized via glucuronidation, sulfation, deglycosylation, hydroxylation, methylation, and dehydroxylation pathways in vivo.